Skandinaviska Enskilda Banken (SEB)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261M | Buy |
|
|||||
|
2025
Q1 | $235M | Buy |
|
|||||
|
2024
Q4 | $167M | Buy |
|
|||||
|
2024
Q3 | $61.3M | Buy |
|
|||||
|
2024
Q2 | $40.2M | Sell |
|
|||||
|
2024
Q1 | $80.4M | Sell |
|
|||||
|
2023
Q4 | $132M | Sell |
|
|||||
|
2023
Q3 | $128M | Buy |
|
|||||
|
2023
Q2 | $124M | Sell |
|
|||||
|
2023
Q1 | $139M | Buy |
|
|||||
|
2022
Q4 | $137M | Buy |
|
|||||
|
2022
Q3 | $93.1M | Sell |
|
|||||
|
2022
Q2 | $98M | Buy |
|
|||||
|
2022
Q1 | $88M | Sell |
|
|||||
|
2021
Q4 | $157M | Buy |
|
|||||
|
2021
Q3 | $133M | Buy |
|
|||||
|
2021
Q2 | $119M | Sell |
|
|||||
|
2021
Q1 | $120M | Buy |
|
|||||
|
2020
Q4 | $91.2M | Sell |
|
|||||
|
2020
Q3 | $114M | Buy |
|
|||||
|
2020
Q2 | $133M | Sell |
|
|||||
|
2020
Q1 | $149M | Sell |
|
|||||
|
2019
Q4 | $204M | Sell |
|
|||||
|
2019
Q3 | $211M | Sell |
|
|||||
|
2019
Q2 | $315M | Buy |
|
|||||
|
2019
Q1 | $279M | Sell |
|
|||||
|
2018
Q4 | $303M | Buy |
|
|||||
|
2018
Q3 | $309M | Buy |
|
|||||
|
2018
Q2 | $73.6M | Buy |
|
|||||
|
2018
Q1 | $71M | Sell |
|
|||||
|
2017
Q4 | $328M | Sell |
|
|||||
|
2017
Q3 | $399M | Buy |
|
|||||
|
2017
Q2 | $106M | Sell |
|
|||||
|
2017
Q1 | $103M | Sell |
|
|||||
|
2016
Q4 | $113M | Sell |
|
|||||
|
2016
Q3 | $134M | Sell |
|
|||||
|
2016
Q2 | $196M | Sell |
|
|||||
|
2016
Q1 | $220M | Sell |
|
|||||
|
2015
Q4 | $257M | Buy |
|